Description
KPV + BPC-157 Arg Blend research blend
KPV + BPC-157 Arg Blend combines KPV, an α-MSH-derived tripeptide, with BPC-157 in its arginate salt form, supplied as tablets, spray or lyophilised peptide.
Product details
| Compound | KPV and BPC-157 arginate |
|---|---|
| Class | Two-peptide research blend |
| Form | Sublingual Tablets; Nasal Spray; Peptide |
| Strength | 750mcg per tab/30ct/22.5mg; 750mcg per tab/60ct/45mg; 600mcg per spray/10ml/60mg; 15mg |
| Labelling | Compound name and strength on every container |
Select your format and strength from the options above.
What KPV + BPC-157 Arg Blend research has examined
- KPV: NF-κB and inflammatory signalling models.
- BPC-157 arginate: gastrointestinal and tissue models.
- Combination research: complementary pathways in intestinal models.
Research interest does not establish a proven effect in humans.
Regulatory status
KPV + BPC-157 Arg Blend is a research blend. None of its components is approved for human use in this form, and it is supplied as a research chemical only.
Storage and handling
Store lyophilised vials cold, dry and away from light. Reconstitute with a suitable sterile diluent under aseptic conditions and keep solutions refrigerated. See our peptide reconstitution guide.
Related research products
KLOW Blend (KPV / GHK-Cu / BPC-157 / TB-500) · Healing and Repair Research Blend: BPC-157 Arg + Thymosin Beta-4 + GHK-Cu · Gastro Inflammation Research Formula (BPC-157, KPV, N-Acetyl Larazotide) · All peptides
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.